Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
KURE
KraneShares MSCI All China Health Care Index ETF
$17.40
-0.1%
$16.47
$12.95
$20.51
$93.09M0.2144,877 shs8,718 shs
ProShares Ultra Health Care stock logo
RXL
ProShares Ultra Health Care
$41.63
+1.6%
$40.20
$36.52
$58.74
$67.86M1.478,636 shs4,842 shs
ALPS Medical Breakthroughs ETF stock logo
SBIO
ALPS Medical Breakthroughs ETF
$32.40
-0.1%
$29.73
$22.33
$42.73
$78.63M0.9212,433 shs2,859 shs
SURI
Simplify Propel Opportunities ETF
$15.58
+1.5%
$15.06
$12.71
$27.52
$68.40M1.573,340 shs652 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
KURE
KraneShares MSCI All China Health Care Index ETF
+1.93%+2.35%0.00%+22.00%+33.92%
ProShares Ultra Health Care stock logo
RXL
ProShares Ultra Health Care
+0.74%+0.07%+1.54%-1.04%-18.40%
ALPS Medical Breakthroughs ETF stock logo
SBIO
ALPS Medical Breakthroughs ETF
+5.87%+5.87%+3.48%+34.94%-6.43%
SURI
Simplify Propel Opportunities ETF
+2.15%+3.77%-2.31%+20.80%-31.11%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
KURE
KraneShares MSCI All China Health Care Index ETF
N/AN/AN/AN/AN/AN/AN/AN/A
ProShares Ultra Health Care stock logo
RXL
ProShares Ultra Health Care
N/AN/AN/AN/AN/AN/AN/AN/A
ALPS Medical Breakthroughs ETF stock logo
SBIO
ALPS Medical Breakthroughs ETF
N/AN/AN/AN/AN/AN/AN/AN/A
SURI
Simplify Propel Opportunities ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
KURE
KraneShares MSCI All China Health Care Index ETF
2.91
Moderate Buy$17.470.37% Upside
ProShares Ultra Health Care stock logo
RXL
ProShares Ultra Health Care
2.68
Moderate Buy$41.63N/A
ALPS Medical Breakthroughs ETF stock logo
SBIO
ALPS Medical Breakthroughs ETF
2.89
Moderate Buy$32.33-0.20% Downside
SURI
Simplify Propel Opportunities ETF
2.62
Moderate Buy$15.58N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
KURE
KraneShares MSCI All China Health Care Index ETF
N/AN/AN/AN/AN/AN/A
ProShares Ultra Health Care stock logo
RXL
ProShares Ultra Health Care
N/AN/AN/AN/AN/AN/A
ALPS Medical Breakthroughs ETF stock logo
SBIO
ALPS Medical Breakthroughs ETF
N/AN/AN/AN/AN/AN/A
SURI
Simplify Propel Opportunities ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
KURE
KraneShares MSCI All China Health Care Index ETF
N/AN/A24.69N/AN/AN/AN/AN/A
ProShares Ultra Health Care stock logo
RXL
ProShares Ultra Health Care
N/AN/A24.86N/AN/AN/AN/AN/A
ALPS Medical Breakthroughs ETF stock logo
SBIO
ALPS Medical Breakthroughs ETF
N/AN/A0.00N/AN/AN/AN/AN/A
SURI
Simplify Propel Opportunities ETF
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
KURE
KraneShares MSCI All China Health Care Index ETF
$0.181.03%N/AN/AN/A
ProShares Ultra Health Care stock logo
RXL
ProShares Ultra Health Care
$0.631.51%N/AN/AN/A
ALPS Medical Breakthroughs ETF stock logo
SBIO
ALPS Medical Breakthroughs ETF
$1.173.61%N/AN/AN/A
SURI
Simplify Propel Opportunities ETF
$2.7217.46%N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
KURE
KraneShares MSCI All China Health Care Index ETF
N/A5.35 millionN/ANot Optionable
ProShares Ultra Health Care stock logo
RXL
ProShares Ultra Health Care
N/A1.63 millionN/ANot Optionable
ALPS Medical Breakthroughs ETF stock logo
SBIO
ALPS Medical Breakthroughs ETF
N/A2.43 millionN/ANot Optionable
SURI
Simplify Propel Opportunities ETF
N/A4.39 millionN/ANot Optionable

Recent News About These Companies

Close-up view of man forming acronym ETF with wooden cubes. A calculator in the composition. — Photo
High-Momentum ETFs Leading the Market This Year (SURI)
...
(SURI) Trading Report
Simplify Propel Opportunities ETF (SURI)
SURI Simplify Propel Opportunities ETF
(SURI) On The My Stocks Page
Best-Performing ETFs of Last Week

New MarketBeat Followers Over Time

Media Sentiment Over Time

KraneShares MSCI All China Health Care Index ETF NYSEARCA:KURE

$17.40 -0.01 (-0.06%)
As of 12:47 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. KURE was launched on Feb 1, 2018 and is managed by KraneShares.

ProShares Ultra Health Care stock logo

ProShares Ultra Health Care NYSEARCA:RXL

$41.63 +0.67 (+1.64%)
As of 12:53 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ProShares Ultra Health Care (the Fund) seeks daily investment results that correspond to twice (200%) the daily performance of the Dow Jones U.S. Health Care Index (the Index). The Fund intends to invest at least 80% of its net assets, including any borrowings for investment purposes, under normal circumstances, to equity securities contained in the Index and/or financial instruments that, in combination, have similar economic characteristics. The Fund also intends to invest assets not invested in financial instruments, in debt instruments and/or money market instruments. The Fund intends to concentrate its investments in a particular industry or group of industries to approximately the same extent as the Index is so concentrated. ProShare Advisors LLC serves as the investment advisor to the Fund.

ALPS Medical Breakthroughs ETF stock logo

ALPS Medical Breakthroughs ETF NYSEARCA:SBIO

$32.40 -0.04 (-0.14%)
As of 12:58 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.

Simplify Propel Opportunities ETF NYSEARCA:SURI

$15.58 +0.23 (+1.50%)
As of 12:39 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The Simplify Propel Opportunities ETF (SURI) is an exchange-traded fund that mostly invests in target outcome asset allocation. The fund employs an actively managed, multi-asset strategy that focuses on equity and debt securities of companies in the healthcare sector. The fund selects securities believed to be attractive investment opportunities SURI was launched on Feb 7, 2023 and is managed by Simplify.